Shilanski & Associates, Inc.: CX position timeline

Shilanski & Associates, Inc. held 30,033 CX shares at 2025-09-30 per its 13F-HR filed 2025-10-20.

the latest 13F is the newest step

1. period ended2025-09-30

   13F 30,033 shares

   Change vs previous 13F +30,033 shares

   0.07% of the 13F portfolio, value $269,997.

   13F-HR 0002063364-25-000226 filed by Shilanski & Associates, Inc.
   Filed 2025-10-20 (acceptance time not in the bulk data set), ingested 2026-10-07 03:02:25 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2024-09-30

   13F 0 shares

   Change vs previous 13F -37,461 shares

   13F-HR 0001754960-24-000556 filed by Shilanski & Associates, Inc.
   Filed 2024-11-12 (acceptance time not in the bulk data set), ingested 2026-10-07 18:26:56 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

3. period ended2024-06-30

   13F 37,461 shares

   Change vs previous 13F +388 shares

   0.08% of the 13F portfolio, value $239,376.

   13F-HR 0001754960-24-000295 filed by Shilanski & Associates, Inc.
   Filed 2024-07-18 (acceptance time not in the bulk data set), ingested 2026-10-07 18:27:57 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2024-03-31

   13F 37,073 shares

   Change vs previous 13F -2,166 shares

   0.12% of the 13F portfolio, value $334,028.

   13F-HR 0001754960-24-000129 filed by Shilanski & Associates, Inc.
   Filed 2024-04-11 (acceptance time not in the bulk data set), ingested 2026-10-07 18:28:46 UTC

   Acceptance time not in the bulk data set (spec §4.2).

5. period ended2023-12-31

   13F 39,239 shares

   Change vs previous 13F not available

   0.12% of the 13F portfolio, value $304,102.

   13F-HR 0001754960-24-000010 filed by Shilanski & Associates, Inc.
   Filed 2024-01-10 (acceptance time not in the bulk data set), ingested 2026-10-07 18:29:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).